Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zhao, Xiao Yan ^a   Yang, Shen ^a   Chen, You Ran ^a   Li, Pei Chun ^a   Dou, Meng Meng ^a   Zhang, Jie ^b  

^a SOUTHWEST UNIVERSITY   (China)

^b Ninth People's Hospital of Chongqing   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CD31 ANTIGEN; CD34 ANTIGEN; REACTIVE OXYGEN METABOLITE; RESVERATROL; VASCULOTROPIN; ANTINEOPLASTIC AGENT; ORGANOARSENIC DERIVATIVE; OXIDE; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL KILLING; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MCF 7 CELL LINE; MOUSE; MTT ASSAY; NB4 CELL LINE; NONHUMAN; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; UTERINE CERVIX CANCER; ANIMAL; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; METABOLISM; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; HUMANS; MALE; MICE; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; OXIDES; REACTIVE OXYGEN SPECIES; STILBENES; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84902532047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098925     Document Type: Article

References (34)

1. 3) in the treatment of acute promyelocytic leukemia (APE).2. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89: 3354-3360.
2. Cyranoski D (2007) Arsenic patent keeps drug for rare cancer out of reach of many. Nature Medicine 13: 1005.
3. Yang J, Li H, Chen YY, Wang XJ, Shi GY, et al. (2004) Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radical Biology and Medicine 37: 2027-2041. (Pubitemid 39491322)
4. 3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. Gynecologic Oncology 106: 400-406.
5. Pettersson HM, Pietras A, Persson MM, Karlsson J, Johansson L, et al. (2009) Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells. Molecular Cancer Therapeutics 8: 160-170.
6. Ma Y, Wang JZ, Liu LX, Zhu HQ, Chen XN, et al. (2011) Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: Role of Akt and nuclear factor-kappa B. Cancer Letters 301: 75-84.
7. Mandal BK, Suzuki KT (2002) Arsenic round the world: a review. Talanta 58: 201-235. (Pubitemid 34857394)
8. Zhang Y, Dong Z, Jin L, Zhang K, Zhao X, et al. (2013) Arsenic trioxide-induced hERG K+ channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression. Biochemical Pharmacology 85: 59-68.
9. Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, et al. (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687-1717.
10. Jang MS, Cai EN, Udeani GO, Slowing KV, Thomas CF, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220. (Pubitemid 127696281)
11. Fremont L (2000) Minireview - Biological effects of resveratrol. Life Sciences 66: 663-673.
12. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al. (2004) Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Research 24: 2783-2840. (Pubitemid 39409568)
13. Corpet DE, Pierre F (2003) Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in Min mice and choice of the model system. Cancer Epidemiology Biomarkers & Prevention 12: 391-400. (Pubitemid 36578475)
14. Fukui M, Yamabe N, Zhu BT (2010) Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. European Journal of Cancer 46: 1882-1891.
15. Zhao XY, Li GY, Liu Y, Chai LM, Chen JX, et al. (2008) Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. British Journal of Pharmacology 154: 105-113. (Pubitemid 351620407)
16. Tong NN, Zhang J, Chen YR, Li ZB, Luo YH, et al. (2012) Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncology Letters 3: 1263-1267.
17. Ding WQ, Liu BL, Vaught JL, Palmiter RD, Lind SE (2006) Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Molecular Cancer Therapeutics 5: 1864-1872. (Pubitemid 44323255)
18. Leite M, Quinta-Costa M, Leite PS, Guimaraes JE (1999) Critical evaluation of techniques to detect and measure cell death - study in a model of UV radiation of the leukaemic cell line HL60. Analytical Cellular Pathology 19: 139-151. (Pubitemid 30321389)
19. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, et al. (2004) VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 104: 788-794. (Pubitemid 38970575)
20. Kamiya H, Kanno T, Fujita Y, Gotoh A, Nakano T, et al. (2012) Apoptosis-Related Gene Transcription in Human A549 Lung Cancer Cells via A(3) Adenosine Receptor. Cellular Physiology and Biochemistry 29: 687-696.
21. Aziz MH, Kumar R, Ahmad N (2003) Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (Review). International Journal of Oncology 23: 17-28.
22. Bianchini F, Vainio H (2003) Wine and resveratrol: mechanisms of cancer prevention? European Journal of Cancer Prevention 12: 417-425. (Pubitemid 37338816)
23. Wang G, Lemos JR, Iadecola C (2004) Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends in Pharmacological Sciences 25: 120-123. (Pubitemid 38264500)
24. Wu EJ, Goussetis DJ, Beauchamp E, Kosciuczuk EM, Altman JK, et al.(2014) Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors. Cancer Biol Ther 15: 473-478.
25. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. Journal of Clinical Investigation 111: 1287-1295. (Pubitemid 36554699)
26. Mancuso MR, Davis R, Norberg SM, O'Brien S, Sennino B, et al. (2006) Rapid vascular regrowth in tumors after reversal of VEGF inhibition. Journal of Clinical Investigation 116: 2610-2621. (Pubitemid 44511625)
27. Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, et al. (1999) VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. British Journal of Cancer 81: 54-61. (Pubitemid 29415491)
28. Zhao XY, Feng TM, Chen H, Shan HL, Zhang Y, et al. (2008) Arsenic trioxideinduced apoptosis in H9c2 cardiomyocytes: Implications in cardiotoxicity. Basic & Clinical Pharmacology & Toxicology 102: 419-425. (Pubitemid 351537783)
29. Dobrydneva Y, Williams RL, Blackmore PF (1999) trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. British Journal of Pharmacology 128: 149-157. (Pubitemid 29425279)
30. Rezk YA, Balulad SS, Keller RS, Bennett JA (2006) Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. American journal of obstetrics and gynecology 194: e23-26.
31. Xin P, Pan YS, Zhu W, Huang SA, Wei M, et al. (2010) Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction. European Journal of Pharmacology 649: 293-300.
32. Zhang WQ, Xue JD, Ge M, Yu ML, Liu L, et al. (2013) Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide. Food and Chemical Toxicology 51: 87-92.
33. Piao FY, Ma N, Hiraku Y, Murata M, Oikawa S, et al. (2005) Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. Journal of Occupational Health 47: 445-449. (Pubitemid 41436309)
34. Borriello A, Bencivenga D, Caldarelli I, Tramontano A, Borgia A, et al. (2014) Resveratrol: from basic studies to bedside. Cancer Treat Res 159: 167-184.